In diabetic cardiomyopathy, it reduced ROS and activated PI3K-AKT signaling pathways, resulting in the downregulation of Bax and caspase-3 expression and consequent apoptosis inhibition [118]. Here, CASP3 is linked to diabetic cardiomyopathy.